# Revenue in the first three months of the year rose to £7.63 billion.

*business · news · 2026-04-29 · The Sunday Times*

## Key points

- GSK's Shingrix vaccine sales rose by 20% to £1 billion this quarter.
- GSK completed a $950 million acquisition of 35Pharma for cardiopulmonary therapies in February.
- GSK is advancing bepirovirsen filings as a potential functional cure for hepatitis B.
- GSK recently received regulatory approvals for exdensur (asthma) and Blenrep (multiple myeloma) in China.

**Companies:** GSK, AstraZeneca
**Countries:** United Kingdom, Canada, China, European Union

[Read the full story on The Sunday Times](https://www.thetimes.com/business/companies-markets/article/gsk-vaccine-sales-profit-revenue-nk9fmr98c)

---

Canonical: https://newsio.io/n/8a123ea6-8b93-4d5d-80b1-430b819c901b/revenue-in-the-first-three-months-of-the-year-rose-to-7-63-billion-vaccine-sales
Summarized by Newsio from The Sunday Times. https://newsio.io/how-it-works